Solid Tumors Clinical Trials

1036 clinical trials for Solid Tumors across international registries, including 201 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Optimizing Ancillary Therapies With Immune Checkpoint Inhibitors for Solid Tumors (OAT ICI) — RECRUITING · PHASE2
• 5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of GEN1106 in Participants With Solid Tumors — RECRUITING · PHASE1
• A study to test different doses of BI 1831169 alone and in combination with an anti-PD-1 antibody in people with different types of advanced cancer (solid tumors) — RECRUITING · PHASE1
• Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity — RECRUITING
• Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment — RECRUITING
• A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies — RECRUITING · PHASE1
• A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma — RECRUITING · PHASE3
• A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours) — RECRUITING · PHASE1
• Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) — RECRUITING · PHASE3
• A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5) — RECRUITING · PHASE2
• A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors — RECRUITING · PHASE1
• Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations — RECRUITING · PHASE1
• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — RECRUITING · PHASE2
• A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies — RECRUITING · PHASE2
• First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy — RECRUITING · PHASE2
• A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Personalized Neoantigen Peptide Vaccines for Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors — RECRUITING · PHASE1
• Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors — RECRUITING · PHASE1
• A Study of ZL-1310 in Participants With Selected Solid Tumors — RECRUITING · PHASE1
• A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation — RECRUITING · PHASE1
• Study of AUBE00 in Patients With Solid Tumors — RECRUITING · PHASE1
• Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials — RECRUITING
• Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors — RECRUITING · PHASE2
• Genomic Profiling in Cancer Patients — RECRUITING
• A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1) — RECRUITING · PHASE1
• Open-label study of BBO-11818 in adult subjects with KRAS mutant cancer — RECRUITING · PHASE1
• A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer — RECRUITING · PHASE1
• A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 — RECRUITING · PHASE1
• Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations — RECRUITING · PHASE1
• Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS) — RECRUITING · PHASE1
• A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Evaluation of the omission of dexamethasone in premedication regimens during paclitaxel treatment — RECRUITING · PHASE3
• A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors — RECRUITING · PHASE2
• JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation — RECRUITING · PHASE1
• Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA) — RECRUITING · PHASE1
• Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients — RECRUITING · PHASE2
• A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults — RECRUITING · PHASE2
• Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors — RECRUITING · PHASE2
• A Study Using White Blood Cells From Healthy Donors To Treat Solid Cancers — RECRUITING · PHASE1
• Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation — RECRUITING · PHASE1
• QTX3034 in Patients With KRAS G12D Mutation — RECRUITING · PHASE1
• ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC — RECRUITING · PHASE1
• A Study of HS-20110 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase I/II Study of MCLA-128, a full length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients with Solid Tumors (eNRGy) — RECRUITING · PHASE2
• Clinical Application of 89Zr-s-C1 PET/CT Imaging in Solid Tumors — RECRUITING

Refine this search